Main > ONCOLOGY (**) > Lymphoma>NHL>T-Cell>CTCL>MF/SS>R/R* > Treat. > Co: JP. K. MogamulizuMAb-Kpkc Inj.>

---

Co: JP. K. MogamulizuMAb-Kpkc Inj.>'s subsections
(*) USA Approval Date: 2018. 08.08.
>for IV Use
Company
MF: Mycosis Fungoides
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2018. 08.07
SS: Sézary Syndrome
TradeMark Product
TradeMark Product PR Web-Site
TradeMark Technology
TradeMark Technology Web-Site

Co: JP. K. MogamulizuMAb-Kpkc Inj.>'s products
This section has no products